Life360, Inc. — Director's Dealing 2021

Dec 14, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Christopher (Chris) Hulls
Date of last notice	15 September 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 282] intentionally omitted <==

----- Start of picture text -----

Direct or indirect interest Direct Interest
Nature of indirect interest N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 8 December 2021 (PST)
No. of securities held prior to change  5,059,656 CHESS Depositary
Interests ( CDIs )

1,225,805 Shares of Common Stock
( Shares )(equivalent to 3,677,415
CDIs)
 1,808,383 Options over Shares
( Options )
 60,237 Restricted Stock Units ( RSUs )
 89,880 CDIs held by ICCA Labs, LLC [1]
Class Shares and RSUs
Number acquired 2,062 Shares
----- End of picture text -----

1 Chris Hulls is a member of ICCA Labs, LLC, an entity that holds Life360 CDIs. The number of CDIs attributable to Chris Hulls by reason of his membership interest in ICCA Labs, LLC is 89,880.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	3,125 RSUs
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	RSUs are granted and vest for no consideration
No. of securities held after change	 5,059,656 CDIs  1,227,867 Shares (equivalent to 3,683,601 CDIs)  1,808,383 Options  57,112 RSUs  89,880 CDIs held by ICCA Labs, LLC
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of Shares following the vesting and settlement of RSUs

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 317] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A
----- End of picture text -----

Part 3 –[+] Closed period

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3